There is no regulatory oversight of AI, which is a *major* problem.
Compared to AI, progress with Neuralink will be slow and easy to assess, as there is large regulatory apparatus approving medical devices. There is no regulatory oversight of AI, which is a *major* problem. I’ve been calling for AI safety regulation for over a decade! — Elon Musk (@elonmusk) December 1, 2022
Compared to AI, progress with Neuralink will be slow and easy to assess, as there is large regulatory apparatus approving medical devices. There is no regulatory oversight of AI, which is a *major* problem. I’ve been calling for AI safety regulation for over a decade!